Related Experiment Video
Updated: Mar 15, 2026

Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice
Published on: August 1, 2025
Trends and Correlates of Cannabis-involved Emergency Department Visits: 2004 to 2011
1Department of Psychiatry and Behavioral Sciences (HZ, L-TW); Department of Medicine (L-TW), Division of General Internal Medicine; Duke Clinical Research Institute (L-TW), Duke University Medical Center; Center for Child and Family Policy (L-TW), Sanford School of Public Policy; and Duke Institute for Brain Sciences (L-TW), Duke University, Durham, NC.
Objectives:
To examine trends and correlates of cannabis-involved emergency department (ED) visits in the United States from 2004 to 2011.
Methods:
Data were obtained from the 2004 to 2011 Drug Abuse Warning Network. We analyzed trend in cannabis-involved ED visits for persons aged ≥12 years and stratified by type of cannabis involvement (cannabis-only, cannabis-polydrug). We used logistic regressions to determine correlates of cannabis-involved hospitalization versus cannabis-involved ED visits only.
Results:
Between 2004 and 2011, the ED visit rate increased from 51 to 73 visits per 100,000 population aged ≥12 years for cannabis-only use (P value for trend = 0.004) and from 63 to 100 for cannabis-polydrug use (P value for trend < 0.001). Adolescents aged 12-17 years showed the largest increase in the cannabis-only-involved ED visit rate (rate difference = 80 per 100,000 adolescents). Across racial/ethnic groups, the most prevalent ED visits were noted among non-Hispanic blacks. Among cannabis-involved visits, the odds of hospitalization (vs ED visits only) increased with age strata compared with age 12 to 17 years.
Conclusions:
These findings suggest a notable increase in the ED visit numbers and rates for both the use of cannabis-only and cannabis-polydrug during the studied period, particularly among young people and non-Hispanic blacks.
Related Concept Videos
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Two synthetic agonists of THC,...
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
Hallucinogens and Psychedelics
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Drug Toxicity: Risk factors
Drug Control Governance: Regulatory Bodies and Their Impact

